Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,819 | -48,782 | -34,104 | -16,191 | -51,010 |
| Depreciation Amortization | 1,409 | 1,002 | 665 | 325 | 1,277 |
| Income taxes - deferred | -1,668 | N/A | N/A | N/A | N/A |
| Accounts receivable | 4,543 | 5,544 | 5,544 | 3,520 | -2,149 |
| Accounts payable and accrued liabilities | 1,196 | 270 | 2,225 | -304 | -663 |
| Other Working Capital | 39,329 | 36,014 | 2,972 | 679 | 24,581 |
| Other Operating Activity | 7,216 | 1,593 | -3,379 | -1,736 | 10,175 |
| Operating Cash Flow | $-14,794 | $-4,359 | $-26,077 | $-13,707 | $-17,789 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,030 | -963 | -794 | -623 | -1,200 |
| Investing Cash Flow | $-2,030 | $-963 | $-794 | $-623 | $-1,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 15,000 | 15,000 | 15,000 | 15,000 |
| Common Stock Issued | 305,725 | 115,061 | 74,611 | 59,059 | 48,416 |
| Other Financing Activity | 15,000 | 0 | 0 | 0 | -573 |
| Financing Cash Flow | $320,725 | $130,061 | $89,611 | $74,059 | $62,843 |
| Exchange Rate Effect | -1,211 | -1,205 | 8 | 182 | 19 |
| Beginning Cash Position | 135,990 | 135,990 | 135,990 | 135,990 | 92,117 |
| End Cash Position | 438,680 | 259,524 | 198,738 | 195,901 | 135,990 |
| Net Cash Flow | $302,690 | $123,534 | $62,748 | $59,911 | $43,873 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,794 | -4,359 | -26,077 | -13,707 | -17,789 |
| Capital Expenditure | -2,030 | -963 | -794 | -623 | -1,200 |
| Free Cash Flow | -16,824 | -5,322 | -26,871 | -14,330 | -18,989 |